THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

Boston Scientific cuts 8% of staff

Effect on Mass. is unclear; 2,300 jobs slashed worldwide

A poster for Boston Scientific at the American College of Cardiology 2006 Summit in Atlanta. Its stent sales have suffered since studies questioned the safety of drug coatings. A poster for Boston Scientific at the American College of Cardiology 2006 Summit in Atlanta. Its stent sales have suffered since studies questioned the safety of drug coatings. (THOMAS S. ENGLAND/BLOOMBERG NEWS/FILE 2006)
By Todd Wallack
Globe Staff / October 18, 2007

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

Boston Scientific Corp. , facing flagging sales for its two key product lines, said late yesterday it will eliminate 2,300 jobs, or 8 percent of its worldwide workforce, restructure parts of its business, and go forward with plans to shed some less-critical assets. (Full article: 794 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $9.95 1 month archives pass
  • $24.95 3 months archives pass
  • $74.95 1 year archives pass